Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fungal endocarditis, 1995-2000.

Lígia C Pierrotti1, Larry M Baddour

  • 1Hospital das Clinicas, University de São Paulo, São Paulo, Brazil.

Chest
|July 13, 2002
PubMed
Summary

Fungal endocarditis (FE) cases show a shift in risk factors, with cardiac abnormalities and prosthetic valves more common than injection drug use. High mortality rates, especially for Aspergillus-related FE, highlight the need for new treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Desired Dose of Doubt: Antibiotic Prophylaxis Prior to Transcatheter Congenital Heart Procedures.

JACC. Advances·2026
Same author

Clinical Features of Adult Patients with Isolated Pulmonary Valve Endocarditis: A Systematic Review.

Microorganisms·2026
Same author

The endocarditis team: a review.

Expert review of anti-infective therapy·2026
Same author

Systemic Embolic Events in People Who Inject Drugs With Patent Foramen Ovale and Right-Sided Infective Endocarditis: A Systematic Review.

Open forum infectious diseases·2026
Same author

Percutaneous Mechanical Aspiration in Patients With Right-Sided Infective Endocarditis: A Science Advisory From the American Heart Association.

Journal of the American Heart Association·2026
Same author

Culture-Negative Infective Endocarditis: The Target Is in the Crosshairs.

Journal of the American College of Cardiology·2026

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Mycology

Background:

  • Fungal endocarditis (FE) is a serious infection affecting heart valves.
  • The epidemiology and risk factors for FE have been evolving.
  • Previous studies may not fully capture current trends in FE.

Purpose of the Study:

  • To analyze the characteristics and outcomes of fungal endocarditis cases.
  • To identify the changing risk factors and predisposing conditions for FE.
  • To assess the current mortality rates associated with FE.

Main Methods:

  • Systematic review of English-language literature.
  • Inclusion of cases diagnosed between January 1, 1995, and June 30, 2000.
  • Data extraction on patient demographics, risk factors, and outcomes.

Main Results:

  • 152 cases of fungal endocarditis were identified.
  • The median patient age was 44 years.
  • Key risk factors included underlying cardiac abnormalities (47.3%), prosthetic valves (44.6%), and central venous catheters (30.4%).
  • Injection drug use was a risk factor in only 4.1% of cases.
  • Mortality rates remain high, particularly for Aspergillus-related FE.

Conclusions:

  • Fungal endocarditis epidemiology has shifted, with non-injection drug use related factors becoming more prevalent.
  • Underlying cardiac conditions and medical devices are significant predisposing factors.
  • Improved and novel therapeutic approaches are crucial to reduce the high mortality associated with fungal endocarditis.

Related Experiment Videos